腫瘍のアブレーション治療の世界市場:治療別(外科手術、腹腔鏡下)、技術別(高周波、マイクロ波、冷凍アブレーション)、用途別、セグメント予測

【英語タイトル】Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Laparoscopic), By Technology (Radiofrequency, Microwave, Cryoablation), By Application, And Segment Forecasts, 2018 - 2025

Grand View Researchが出版した調査資料(GVW8NV192)・商品コード:GVW8NV192
・発行会社(調査会社):Grand View Research
・発行日:2018年8月
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥1,176,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,472,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
腫瘍のアブレーション治療の世界市場は2025年には21億6,000万米ドルに達し、予測期間中、年平均成長率11.12%で成長すると予測されています。この市場の成長を促す要因として、がんの罹患率が高いことが考えられます。世界保健機関(WHO)の統計によると、毎年人口の約13.0%ががんに罹患しています。 外傷が最小で済むこと、迅速な回復が望めることで、低侵襲外科手術が幅広く採用され、結果として市場の成長につながると期待されています。本調査レポートでは、腫瘍のアブレーション治療の世界市場について調査・分析し、腫瘍のアブレーション治療の世界市場動向、腫瘍のアブレーション治療の世界市場規模、市場予測、セグメント別腫瘍のアブレーション治療市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global tumor ablation market size is anticipated to reach USD 2.16 billion by 2025, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.12% over the forecast period. High prevalence of cancer across the globe is the key market driver. About 13.0% of population suffers from cancer each year, as per the statistics by the World Health Organization (WHO). Extensive adoption of minimally invasive procedures due to the benefits such as less trauma, speedy recovery, and faster recovery is anticipated to bode well for market expansion.
Increasing demand for minimally invasive surgeries coupled with technological advancements in thermal ablation is anticipated to boost market growth. For instance, Usage of cooled radiofrequency denervation technique-a procedure that uses radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint-with internally cooled radiofrequency probes to enlarge size of the lesion. Similarly, in February 2015, SonaCare Medical LLC launched Sonalink-a remote patient monitoring platform-that can be used during HIFU procedures.

In addition, rising per capita income is enabling people to opt for advanced treatment for tumors. This factor is anticipated to positively influence market growth over the forecast period. Active role of healthcare agencies and government in creating awareness about various cancer types is expected to facilitate usage of tumor ablation therapy.

Further key findings from the study suggest:

• Radiofrequency emerged as the dominant technology segment with 30.5% share in 2016 attributed to application in removal of solid tumors

• Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety

• Lung cancer is anticipated to witness substantial growth owing to high prevalence caused by sedentary lifestyle, rise in smoking, and air pollution

• North America dominated the overall market in the past due to high prevalence of cancer in Canada, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

• Major players operating in the tumor ablation market include, Galil Medical Inc.; Misonix Inc.; HealthTronics, Angiodynamics; Boston Scientific Corporation; Medtronic Plc. (Covidien); SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc.

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.3.1 Region Wise Market: Base Estimates
2.3.2 Global Market: CAGR Calculation
2.4 Region based segment share calculation
2.5 List of Secondary Sources (partial list)
2.6 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising incidence of cancer
3.2.2 Technological advancements in ablation devices
3.2.3 Increasing per capita income
3.2.4 Growing demand of minimally invasive surgeries
3.3 Market Restraint Analysis
3.3.1 Complications associated with Tumor Ablation therapy
3.3.2 Stringent regulations & approvals
3.4 Penetration & Growth Prospect Mapping: Product
3.5 Tumor Ablation Market c SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1 Tumor ablation market: Technology movement analysis
4.2 Radiofrequency ablation
4.2.1 Global radiofrequency ablation market, 2014 – 2025 (USD Million)
4.3 Microwave ablation
4.3.1 Global microwave ablation market, 2014 – 2025 (USD Million)
4.4 Cryoablation
4.4.1 Global cryoablation market, 2014 – 2025 (USD Million)
4.5 Irreversible electroporation
4.5.1 Global irreversible electroporation market, 2014 – 2025 (USD Million)
4.6 Other ablation technologies
4.6.1 Global other ablation technologies market, 2014 – 2025 (USD Million)
Chapter 5 Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1 Tumor Ablation market: Treatment movement analysis
5.2 Surgical ablation
5.2.1 Global surgical ablation market 2014-2025
5.3 Laparoscopic ablation
5.3.1 Global laparoscopic ablation market 2014-2025
5.4 Percutaneous ablation
5.4.1 Global percutaneous ablation market 2014-2025
Chapter 6 Tumor Ablation Market: Application Estimates & Trend Analysis
6.1 Tumor Ablation market: Application movement analysis
6.2 Liver cancer
6.2.1 Global liver cancer 2014-2025
6.3 Breast cancer
6.3.1 Global breast cancer 2014-2025
6.4 Lung cancer
6.4.1 Global lung cancer 2014-2025
6.5 Prostate cancer
6.5.1 Global prostate cancer market, 2014-2025
6.6 Other cancer
6.6.1 Global other cancer market, 2014-2025
Chapter 7 Market Share Analysis
7.1 Market share analysis: HIFU competitive analysis
7.1.1 Insightec
7.1.2 SonaCare Medical
7.1.3 EDAP
7.1.4 FUS Instruments
7.1.5 Sonic Concept
7.1.6 Haifu
Chapter 8 Regional Estimates & Trend Analysis, by Technology, Treatment, & Application
8.1 Tumor ablation market share by region, 2017 & 2025
8.2 North America
8.2.1 North America tumor ablation market, 2014 – 2025 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Tumor ablation market, 2014 – 2025 (USD Million)
8.2.3 Canada
8.2.3.1 Canada tumor ablation market, 2014 – 2025 (USD Million)
8.3 Europe
8.3.1 Europe tumor ablation market, 2014 – 2025 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. tumor ablation market, 2014 – 2025 (USD Million)
8.3.3 Germany
8.3.3.1 Germany tumor ablation market, 2014 – 2025 (USD Million)
8.3.4 France
8.3.4.1 France tumor ablation market, 2014 – 2025 (USD Million)
8.3.5 Italy
8.3.5.1 Italy tumor ablation market, 2014 – 2025 (USD Million)
8.3.6 Spain
8.3.6.1 Spain tumor ablation market, 2014 – 2025 (USD Million)
8.3.7 Belgium
8.3.7.1 Belgium tumor ablation market, 2014 – 2025 (USD Million)
8.3.8 Switzerland
8.3.8.1 Switzerland tumor ablation market, 2014 – 2025 (USD Million)
8.3.9 Poland
8.3.9.1 Poland tumor ablation market, 2014 – 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific tumor ablation market, 2014 – 2025 (USD Million)
8.4.2 Japan
8.4.2.1 Japan tumor ablation market, 2014 – 2025 (USD Million)
8.4.3 China
8.4.3.1 China tumor ablation market, 2014 – 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America tumor ablation market, 2014 – 2025 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil tumor ablation market, 2014 – 2025 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico tumor ablation market, 2014 – 2025 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa tumor ablation market, 2014 – 2025 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa tumor ablation market, 2014 – 2025 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Medtronic
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 AngioDynamics
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Mermaid Medical
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.4 HealthTronics, Inc.
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Galil Medical, Inc.
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Service Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 EDAP TMS
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Boston Scientific Corporation
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives
9.1.8 SonaCare Medical LLC
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 Misonix
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 NeuWave Medical, Inc.
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11 ERBE Elektromedizin GmbH
9.1.11.1 Company Overview
9.1.11.2 Financial Performance
9.1.11.3 Product Benchmarking
9.1.12 Biotronik
9.1.12.1 Company Overview
9.1.12.2 Financial Performance
9.1.12.3 Product Benchmarking

List of Tables

TABLE 1 North America tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 2 North America tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 3 North America tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 4 U.S. tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 5 U.S. tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 6 U.S. tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 7 Canada tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 8 Canada tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 9 Canada tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 9 Europe tumor ablation market estimates and forecast by technology, 2014-2025, (USD Million)
TABLE 10 Europe tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 11 Europe tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 12 U.K tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 13 U.K tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 14 U.K tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 15 Germany tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 16 Germany tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 17 Germany tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 18 France tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 19 France tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 20 France tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 21 Italy tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 22 Italy tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 23 Italy tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 24 Spain tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 25 Spain tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 26 Spain tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 27 Belgium tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 28 Belgium tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 29 Belgium tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 30 Switzerland tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 31 Switzerland tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 32 Switzerland tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 33 Poland tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 34 Poland tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 35 Poland tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 36 Asia Pacific tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 37 Asia Pacific tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 38 Asia Pacific tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 39 China tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 40 China tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 41 China tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 42 Japan tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 43 Japan tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 44 Japan tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 45 Latin America tumor ablation market estimates and forecast by technology, 2014-2025, (USD Million)
TABLE 46 Latin America tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 47 Latin America tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 48 Brazil tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 49 Brazil tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 50 Brazil tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 51 Mexico tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 52 Mexico tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 53 Mexico tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 54 Middle East Asia tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 55 Middle East Asia tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 56 Middle East Asia tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)
TABLE 57 South Africa tumor ablation market estimates and forecast by technology, 2014 - 2025 (USD Million)
TABLE 58 South Africa tumor ablation market estimates and forecast by treatment, 2014 - 2025 (USD Million)
TABLE 59 South Africa tumor ablation market estimates and forecast by application, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million), 2017
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 9 Market driver relevance analysis (Current & future impact)
FIG. 10 Increasing Purchasing Power Parity (PPP), USD , 2011 - 2014
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 14 Porter’s five forces analysis
FIG. 15 Tumor ablation market: Technology outlook key takeaways
FIG. 16 Tumor Ablation market: Technology movement analysis
FIG. 17 Global radiofrequency ablation market, 2014 - 2025 (USD Million)
FIG. 18 Global microwave market, 2014 - 2025 (USD Million)
FIG. 19 Global cryoablation market, 2014 - 2025 (USD Million)
FIG. 20 Global electroporation market, 2014 - 2025 (USD Million)
FIG. 21 Global other ablation technologies market, 2014 - 2025 (USD Million)
FIG. 22 Tumor ablation market: Treatment outlook key takeaways
FIG. 23 Tumor Ablation market: Treatment movement analysis
FIG. 24 Global surgical ablation market, 2014 - 2025 (USD Million)
FIG. 25 Global laparoscopic ablation market, 2014 - 2025 (USD Million)
FIG. 26 Global percutaneous ablation market, 2014 - 2025 (USD Million)
FIG. 27 Tumor ablation market: Application outlook key takeaways
FIG. 28 Tumor Ablation market: Application movement analysis
FIG. 29 Global liver cancer market, 2014 - 2025 (USD Million)
FIG. 30 Global breast cancer market, 2014 - 2025 (USD Million)
FIG. 31 Global lung cancer market, 2014 - 2025 (USD Million)
FIG. 32 Global prostate cancer market, 2014 - 2025 (USD Million)
FIG. 33 Global other cancer market, 2014 - 2025 (USD Million)
FIG. 34 Market share analysis, 2017
FIG. 35 Regional market place: Key takeaways
FIG. 36 Regional outlook, 2017 & 2025
FIG. 37 North America tumor ablation market, 2014 - 2025 (USD Million)
FIG. 38 U.S. Tumor ablation market, 2014 - 2025 (USD Million)
FIG. 39 Canada tumor ablation market, 2014 - 2025 (USD Million)
FIG. 40 Europe tumor ablation market, 2013 - 2024 (USD Million)
FIG. 41 U.K. tumor ablation market, 2013 - 2024 (USD Million)
FIG. 42 Germany tumor ablation market, 2014 - 2025 (USD Million)
FIG. 43 France tumor ablation market, 2014 - 2025 (USD Million)
FIG. 44 Italy tumor ablation market, 2014 - 2025 (USD Million)
FIG. 45 Spain tumor ablation market, 2014 - 2025 (USD Million)
FIG. 46 Belgium tumor ablation market, 2014 - 2025 (USD Million)
FIG. 47 Switzerland tumor ablation market, 2014 - 2025 (USD Million)
FIG. 48 Poland tumor ablation market, 2014 - 2025 (USD Million)
FIG. 49 Asia Pacific tumor ablation market, 2014 - 2025 (USD Million)
FIG. 50 Japan tumor ablation market, 2014 - 2025 (USD Million)
FIG. 51 China tumor ablation market, 2014 - 2025 (USD Million)
FIG. 52 Latin America tumor ablation market, 2014 - 2025 (USD Million)
FIG. 53 Brazil tumor ablation market, 2014 - 2025 (USD Million)
FIG. 54 Mexico tumor ablation market, 2014 - 2025 (USD Million)
FIG. 54 Middle East & Africa tumor ablation market, 2014 - 2025 (USD Million)
FIG. 56 South Africa tumor ablation market, 2014 - 2025 (USD Million)
FIG. 57 Strategy framework

【掲載企業】

Medtronic
AngioDynamics
Mermaid Medical
HealthTronics, Inc.
Galil Medical, Inc.
EDAP TMS
Boston Scientific Corporation
SonaCare Medical LLC
Misonix
NeuWave Medical, Inc.
ERBE Elektromedizin GmbH
Biotronik

★調査レポート[腫瘍のアブレーション治療の世界市場:治療別(外科手術、腹腔鏡下)、技術別(高周波、マイクロ波、冷凍アブレーション)、用途別、セグメント予測] (コード:GVW8NV192)販売に関する免責事項を必ずご確認ください。
★調査レポート[腫瘍のアブレーション治療の世界市場:治療別(外科手術、腹腔鏡下)、技術別(高周波、マイクロ波、冷凍アブレーション)、用途別、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆